To add an entry, seeWikipedia:WikiProject_Medicine/Tools#Requests. This article is intended to be "a complete list of titles from one specific source, not a general list of potential cancer related articles"[1]

This list contains subjects important tocancer research.

Prior to pruning, this list contained 5,004 entries. Before removing blue links from this list, please check them to make sure they actually cover the intended subject.

Public domain sources:Dictionary of Cancer Terms

1. ABT-751
2. AD 32 - currently redirects into year 32
3. AE-941
4. AG2037
5. Adjunct agent
6. Aerosolize
7. Aminocamptothecin
8. Androgen-independent
9. Antiapoptotic
10. Antisense c-fos
11. Arginine butyrate
12. Autologous bone marrow
13. Axillary lymph node dissection
14. B3 antigen
15. B43-PAP immunotoxin
16. BAY 12-9566
17. BAY 43-9006
18. BAY 56-3722
19. BAY 59-8862
20. BB-10901
21. BBBD
22. BBIC
23. BG00001
24. BIBX 1382
25. BI 2536
26. BL22 immunotoxin
27. BMS-184476
28. BMS-188797
29. BMS-214662
30. BMS-275291
31. BMS-599626
32. Benzoylphenylurea
33. Beriplast P
34. Beta alethine
35. Biafine cream
36. Bilateral cancer
37. Bilateral prophylactic mastectomy
38. Biochemical reactions
39. Bizelesin
40. Bone marrow ablation
41. Bone marrow metastases
42. Boronophenylalanine-fructose complex
43. Bowman-Birk inhibitor concentrate
44. Breast density
45. CC-8490
46. CC49-streptavidin
47. CEA assay
48. CEP-2563 dihydrochloride
49. CGP 48664
50. CHS 828
51. CI-958
52. CI-980
53. CI-994
54. CNS sanctuary therapy
55. CNS tumor
56. CP-547,632
57. CP-609,754
58. CP-724,714
59. CP4071
60. CT-2584
61. Camptothecin analog
62. Carbon-11 acetate
63. Carboxypeptidase-G2
64. Carcinostatic
65. Carzelesin
66. Central nervous system metastasis
67. Central nervous system sanctuary therapy
68. Child-life worker
69. Chloroquinoxaline sulfonamide
70. Chronic lymphoblastic leukemia
71. Chronic phase
72. Clinical breast exam
73. Clinical resistance
74. Coactivated T cell
75. Complete metastasectomy
76. Concurrent therapy
77. Consensus Development Program
78. Consolidation therapy
79. Constitutional acupuncture
80. Contiguous lymphoma
81. Continent reservoir
82. Continuous infusion
83. Control animal
84. Controlled low-voltage electrical stimulation
85. CpG 7909
86. Crisnatol mesylate
87. Cutaneous breast cancer
88. Cytochlor
89. Cytotoxic chemotherapy
90. D-20761
91. DTGM fusion protein
92. DX-52-1
93. De qi sensation
94. Dendritic cell vaccine
95. DepoFoam-encapsulated cytarabine
96. Dextroamphetamine-amphetamine
97. Dextromethorphan acetic acid
98. Di-dgA-RFB4
99. Diagnostic trial
100. Diaziquone
101. Dietary protocol
102. Dihematoporphyrin ether
103. Dimesna
104. Dimethylxanthenone acetic acid
105. Disease-specific survival
106. Distant cancer
107. Dolastatin 10
108. Dose-limiting
109. Dose-rate
110. EKB-569
111. EMD 121974
112. EP-2101
113. EPO906
114. ERUS
115. Early-stage breast cancer
116. Ectocervical
117. Edatrexate
118. Edotecarin
119. Electroporation therapy
120. Eligibility criteria
121. Emitefur
122. Endocrine cancer
123. Endometrial disorder
124. Endorectal ultrasound
125. Eniluracil
126. Epithelial carcinoma
127. Erb-38 immunotoxin
128. Erythroleukoplakia
129. Ethynyluracil
130. Evaluable disease
131. Evaluable patients
132. Ewing's family of tumors
133. Exatecan mesylate
134. Extensive-stage small cell lung cancer
135. External-beam radiation
136. External radiation
137. Extracranial
138. Extragonadal germ cell tumor
139. Extrahepatic
140. Extrapleural pneumonectomy
141. Fast-neutron beam radiation
142. Fazarabine
143. Fenretinide LXS
144. Fenretinide Lym-X-Sorb
145. Ferumoxtran-10
146. Filgrastim-SD/01
147. Five element acupuncture
148. Fluorine F 18 EF5
149. Fluorothymidine F 18
150. Follicular mixed cell lymphoma
151. Forodesine hydrochloride
152. GEM 231
153. GI14721
154. GM2-KLH vaccine
155. GPX-100
156. GTI-2040
157. GW786034
158. Gadolinium texaphyrin
159. Gail model
160. Gastric atrophy
161. Gastrointestinal carcinoid tumor
162. Geldanamycin analog
163. Gene-modified
164. Germ-free
165. Gimatecan
166. Glycinamide ribonucleotide formyltransferase inhibitor
167. Gp209-2M
168. Gp96 HSP-peptide complex
169. Gp96 heat shock protein-peptide complex vaccine
170. Grade 1 follicular lymphoma
171. Grade 2 follicular lymphoma
172. Grade 3 follicular lymphoma
173. Gray elm
174. HCD20
175. HCRF
176. HIV antibody
177. Halofuginone hydrobromide
178. Hawthorn fruit
179. Hematogenous
180. Hematologic cancer
181. Hematopoietic tissue
182. Hematoporphyrin derivative
183. Hemilaryngectomy
184. Hepatic arterial occlusion
185. Herba scutellaria barbatae
186. Heterogenic
187. Hexyl 5-aminolevulinate
188. High-dose-rate remote brachytherapy
189. High-dose-rate remote radiation therapy
190. High-dose radiation
191. High-energy photon therapy
192. High-grade squamous intraepithelial lesion
193. High-risk cancer
194. High grade
195. Histiocytic lymphoma
196. Histologic examination
197. Historical control subject
198. Holmium Ho 166 DOTMP
199. Hormone receptor test
200. Hormone responsive
201. Hot nodule
202. Hu14.18-interleukin-2 fusion protein
203. Hu3S193
204. HuHMFG1
205. Huang Lian
206. Hurthle cell neoplasm
207. IBMFS
208. ICI D1694
209. IDEC-Y2B8
210. IH636 grape seed extract
211. ILX-295501
212. ILX23-7553
213. IM-862
214. INS316
215. ISIS 2503
216. ISIS 3521
217. ISIS 5132
218. Imaging procedure
219. Immune system tolerance
220. Immunoassay fecal occult blood test
221. Immunochemical fecal occult blood test
222. Immunologic fecal occult blood test
223. Implantable pump
224. In situ cancer
225. Incomplete Freund's adjuvant
226. Indian valerian
227. Indium In 111 pentetreotide
228. Induction therapy
229. Infiltrating cancer
230. Infrared coagulation
231. Inherited bone marrow failure syndrome
232. Intensification therapy
233. Intensity-modulated radiation therapy
234. Interfering thought
235. Interleukin-13 PE38QQR immunotoxin
236. Interleukin-4 PE38KDEL cytotoxin
237. Interleukin-4 PE38KDEL immunotoxin
238. Intermediate-grade lymphoma
239. Interstitial radiation
240. Intervention group
241. Intoplicine
242. Intoxicating pepper
243. Intracarotid infusion
244. Intracavitary
245. Intracavitary radiation
246. Intracolonic
247. Intracutaneous
248. Intraepithelial
249. Intrahepatic
250. Intrahepatic infusion
251. Intralesional
252. Intraluminal intubation and dilation
253. Intraocular
254. Intrapelvic
255. Intraperitoneal infusion
256. Intraperitoneal radiation therapy
257. Intraspinal
258. Intrathecal chemotherapy
259. Intratumoral
260. Intraventricular infusion
261. Invasive cervical cancer
262. Investigational
263. Iodine I 131 monoclonal antibody BC8
264. Iododoxorubicin
265. Irreversible toxicity
266. Iseganan hydrochloride
267. Isointense
268. J-107088
269. Jiang huang
270. KOS-862
271. KRN5500
272. KW2189
273. Karenitecin
274. Korean acupuncture
275. L-377,202
276. L-778,123
277. L-threo-dihydrosphingosine
278. LED therapy
279. LEP-ETU
280. LMB-1 immunotoxin
281. LMB-2 immunotoxin
282. LMB-7 immunotoxin
283. LMB-9 immunotoxin
284. LU-103793
285. LU 79553
286. LY353381 hydrochloride
287. Labial mucosa
288. Laboratory study
289. Laparoscopic-assisted colectomy
290. Laparoscopic prostatectomy
291. Laser acupuncture
292. Leptomeningeal metastases
293. Leridistim
294. Leuvectin
295. Limited-stage small cell lung cancer
296. Liposomal SN-38
297. Liquid-based Pap test
298. Liver scan
299. Lobradimil
300. Local cancer
301. Local therapy
302. Localized gallbladder cancer
303. Localized malignant mesothelioma
304. Locally advanced cancer
305. Lometrexol
306. Low-grade lymphoma
307. Low grade
308. Lung metastases
309. Luteinizing hormone-releasing hormone agonist
310. Lymph node drainage
311. Lymph node mapping
312. Lymphatic basin
313. Lymphatic mapping
314. Lytic lesion
315. MDL 101,731
316. MDX-060
317. MG98
318. MLN2704
319. MLN591DM1
320. MS 209
321. Mantle field
322. Maximum inspiratory pressure test
323. MeV linear accelerator
324. Mean survival time
325. Measurable disease
326. Medical oncologist
327. Mega-voltage linear accelerator
328. Meningeal metastases
329. Mesenteric membrane
330. Metasynchronous
331. Microwave acupuncture
332. Mistletoe lectin
333. Mitolactol
334. Mitotic activity
335. Mivobulin isethionate
336. Montanide ISA-51
337. MuJ591
338. Mucin/peptide
339. Multicentric breast cancer
340. Multidisciplinary opinion
341. Multidrug resistance inhibition
342. Multifocal breast cancer
343. Multimodality treatment
344. Mycosis fungoides plaque
345. Myelogenous
346. Myelosuppressive therapy
347. N-acetyldinaline
348. N-benzoyl-staurosporine
349. N-butyl-N-(4-hydroxybutyl) nitrosamine
350. NBI-3001
351. NCI clinical trials cooperative group
352. NGR-TNF
353. NR-LU-10 antigen
354. NSC 655649
355. Nanoparticle paclitaxel
356. Nasoscopy
357. Negative axillary lymph node
358. Negative test result
359. Nephrotomogram
360. Nephroureterectomy
361. Nerve-sparing radical prostatectomy
362. Nerve grafting
363. Neurobehavioral
364. Neuroepithelial
365. Node-negative
366. Node-positive
367. Nonblinded
368. Noncontiguous lymphoma
369. Nonfunctioning tumor
370. Nonhematologic cancer
371. Nonlytic
372. Nonmalignant
373. Nonmalignant hematologic disorder
374. Nonmelanomatous
375. Nonmetastatic
376. Nonopioid
377. Nonprescription
378. Nonrandomized clinical trial
379. Nonsteroidal aromatase inhibitor
380. Nuclear medicine scan
381. Nutritional status
382. OGX-011
383. OTI-010
384. OXi-104
385. Objective improvement
386. Objective response
387. Occult stage non-small cell lung cancer
388. Oncology pharmacy specialist
389. Oncolysate
390. Oncolysis
391. Open colectomy
392. Ovarian ablation
393. Ovarian suppression
394. PALA
395. PEG-MGDF
396. PEG-asparaginase
397. PEG-rhMGDF
398. PF-3512676
399. PI-88
400. PM-81
401. PN401
402. PNU-93914
403. PNU 166148
404. PSC 833
405. PTCD
406. PV701
407. Pacific valerian
408. Paclitaxel (Albumin-Stabilized Nanoparticle Formulation)
409. Paclitaxel liposome
410. Paclitaxel poliglumex
411. Paclitaxel polyglutamate
412. Palmar-plantar erythodysthesia
413. Palpable disease
414. Papillary serous carcinoma
415. Partial hysterectomy
416. Partial laryngectomy
417. Partial mastectomy
418. Partial oophorectomy
419. Partial response
420. Pathology report
421. Pediatric nurse specialist
422. Pegylated liposomal doxorubicin
423. Peldesine
424. Pelvic lymphadenectomy
425. Penclomedine
426. Pentetic acid calcium
427. Peptide 946
428. Percutaneous transhepatic biliary drainage
429. Perfusion magnetic resonance imaging
430. Perineal colostomy
431. Perineal prostatectomy
432. Perineural
433. Peripheral primitive neuroectodermal tumor
434. Peripheral stem cell
435. Peritoneal infusion
436. Peritoneal perfusion
437. Phase II detoxification
438. Phase I detoxification
439. Phenoxodiol
440. Phospholipid complex
441. Photoactivity
442. Photon-beam radiation
443. Pineal region tumor
444. Piritrexim
445. Placebo therapy
446. Placental blood transplantation
447. Plasmacytic
448. Polifeprosan 20 carmustine implant
449. Polyethylene glycosylated recombinant human megakaryocyte
450. Polyglutamate camptothecin
451. Positive test result
452. Posterior pelvic exenteration
453. Postremission therapy
454. Precancerous polyps
455. Predictive factor
456. Pretracheal space
457. Prevascular space
458. Preventive
459. Progesterone receptor negative
460. Progesterone receptor positive
461. Progesterone receptor test
462. Prognostic factor
463. Proliferating
464. Prophylactic oophorectomy
465. Prost 30
466. Prostatocystectomy
467. Proteomic profile
468. Proton magnetic resonance spectroscopic imaging
469. Pulmonary rehabilitation education
470. Purple clover
471. Pyrazine diazohydroxide
472. Pyrazoloacridine
473. Pyroxamide
474. R101933
475. RAV12
476. RK-0202
477. RMP-7
478. RPR 109881A
479. Radiation fibrosis
480. Radiation nurse
481. Radiation physicist
482. Radiation surgery
483. Radical cystectomy
484. Radical local excision
485. Radical nephrectomy
486. Radioactive palladium
487. Radioactive seed
488. Radiologic exam
489. Radionuclide scanning
490. Radiosensitization
491. Rapid-onset opioid
492. Ras peptide
493. Rebeccamycin analog
494. Rectal reconstruction
495. Regional cancer
496. Regional chemotherapy
497. Regional lymph node
498. Regional lymph node dissection
499. Rehabilitation specialist
500. Remission induction therapy
501. Remote brachytherapy
502. Replication cycle
503. Resectable
504. Resected
505. Residual disease
506. Retromolar trigone
507. Retroviral vector
508. RevM10 gene
509. Ro 31-7453
510. Ro 50-3821
511. S-phase fraction
512. SB-715992
513. SC-70935
514. SCH-58500
515. SCH 54031
516. SCH 66336
517. SGN-00101
518. SGN-15
519. SGN-30
520. SJG-136
521. SL-11047
522. SN-38 liposome
523. SR-29142
524. SR-45023A
525. ST1481
526. SU006668
527. SU6668
528. SarCNU
529. Sarcosinamide nitrosourea
530. Second-look surgery
531. Second primary cancer
532. Sedoxantrone trihydrochloride
533. Segmental cystectomy
534. Seminal vesicle biopsy
535. Semiparasitic
536. Seocalcitol
537. Sequential treatment
538. Serum tumor marker test
539. Sestamibi breast imaging
540. Severe myelosuppression
541. Sialyl Tn-KLH
542. Silicon phthalocyanine 4
543. Simple mastectomy
544. Simple nephrectomy
545. Skin stimulation
546. Skinning vulvectomy
547. SnET2
548. Soblidotin
549. Sodium borocaptate
550. Somnolence syndrome
551. Specific immune cell
552. Sputum cytology
553. Stable disease
554. Stage 0 anal cancer
555. Stage 0 bladder cancer
556. Stage 0 cervical cancer
557. Stage 0 chronic lymphocytic leukemia
558. Stage 0 colorectal cancer
559. Stage 0 esophageal cancer
560. Stage 0 extrahepatic bile duct cancer
561. Stage 0 gallbladder cancer
562. Stage 0 gastric cancer
563. Stage 0 hypopharyngeal cancer
564. Stage 0 laryngeal cancer
565. Stage 0 melanoma
566. Stage 0 nasopharyngeal cancer
567. Stage 0 non-small cell lung cancer
568. Stage 0 skin cancer
569. Stage 0 testicular cancer
570. Stage 0 transitional cell cancer of the renal pelvis and ureter
571. Stage 1 neuroblastoma
572. Stage 2 neuroblastoma
573. Stage 3 neuroblastoma
574. Stage 4 neuroblastoma
575. Stage A1 prostate cancer
576. Stage A2 prostate cancer
577. Stage B1 prostate cancer
578. Stage B2 prostate cancer
579. Stage C prostate cancer
580. Stage D1 prostate cancer
581. Stage D2 prostate cancer
582. Stage IA gallbladder cancer
583. Stage IA soft tissue sarcoma
584. Stage IB gallbladder cancer
585. Stage IB soft tissue sarcoma
586. Stage IIA breast cancer
587. Stage IIA gallbladder cancer
588. Stage IIA soft tissue sarcoma
589. Stage IIB breast cancer
590. Stage IIB gallbladder cancer
591. Stage IIB melanoma
592. Stage IIB soft tissue sarcoma
593. Stage IIC soft tissue sarcoma
594. Stage IIIA adult primary liver cancer
595. Stage IIIA anal cancer
596. Stage IIIA breast cancer
597. Stage IIIB adult primary liver cancer
598. Stage IIIB anal cancer
599. Stage IIIB breast cancer
600. Stage IIIC adult primary liver cancer
601. Stage IIIC breast cancer
602. Stage III AIDS-related lymphoma
603. Stage III Wilms' tumor
604. Stage III adrenocortical cancer
605. Stage III adult Hodgkin's lymphoma
606. Stage III adult non-Hodgkin's lymphoma
607. Stage III anal cancer
608. Stage III bladder cancer
609. Stage III breast cancer
610. Stage III cancer of the uterus
611. Stage III cancer of the vulva
612. Stage III cervical cancer
613. Stage III childhood liver cancer
614. Stage III childhood non-Hodgkin's lymphoma
615. Stage III chronic lymphocytic leukemia
616. Stage III colorectal cancer
617. Stage III cutaneous T-cell lymphoma
618. Stage III endometrial cancer
619. Stage III esophageal cancer
620. Stage III extrahepatic bile duct cancer
621. Stage III gallbladder cancer
622. Stage III gastric cancer
623. Stage III hypopharyngeal cancer
624. Stage III kidney cancer
625. Stage III laryngeal cancer
626. Stage III lip and oral cavity cancer
627. Stage III malignant mesothelioma
628. Stage III melanoma
629. Stage III mycosis fungoides and the Sézary syndrome
630. Stage III nasopharyngeal cancer
631. Stage III non-small cell lung cancer
632. Stage III oropharynx cancer
633. Stage III ovarian cancer
634. Stage III pancreatic cancer
635. Stage III prostate cancer
636. Stage III renal cell cancer
637. Stage III skin cancer
638. Stage III soft tissue sarcoma
639. Stage III testicular cancer
640. Stage III transitional cell cancer of the renal pelvis and ureter
641. Stage II AIDS-related lymphoma
642. Stage II Wilms' tumor
643. Stage II adrenocortical cancer
644. Stage II adult Hodgkin's lymphoma
645. Stage II adult non-Hodgkin's lymphoma
646. Stage II adult primary liver cancer
647. Stage II anal cancer
648. Stage II bladder cancer
649. Stage II breast cancer
650. Stage II cancer of the uterus
651. Stage II cancer of the vulva
652. Stage II cervical cancer
653. Stage II childhood liver cancer
654. Stage II childhood non-Hodgkin's lymphoma
655. Stage II chronic lymphocytic leukemia
656. Stage II colorectal cancer
657. Stage II cutaneous T-cell lymphoma
658. Stage II endometrial cancer
659. Stage II esophageal cancer
660. Stage II extrahepatic bile duct cancer
661. Stage II gastric cancer
662. Stage II hypopharyngeal cancer
663. Stage II kidney cancer
664. Stage II laryngeal cancer
665. Stage II lip and oral cavity cancer
666. Stage II malignant mesothelioma
667. Stage II melanoma
668. Stage II multiple myeloma
669. Stage II mycosis fungoides and the Sézary syndrome
670. Stage II nasopharyngeal cancer
671. Stage II non-small cell lung cancer
672. Stage II oropharynx cancer
673. Stage II ovarian cancer
674. Stage II pancreatic cancer
675. Stage II prostate cancer
676. Stage II renal cell cancer
677. Stage II skin cancer
678. Stage II testicular cancer
679. Stage II transitional cell cancer of the renal pelvis and ureter
680. Stage IVA hypopharyngeal cancer
681. Stage IVA laryngeal cancer
682. Stage IVA pancreatic cancer
683. Stage IVB hypopharyngeal cancer
684. Stage IVB laryngeal cancer
685. Stage IVB pancreatic cancer
686. Stage IVC hypopharyngeal cancer
687. Stage IVC laryngeal cancer
688. Stage IV AIDS-related lymphoma
689. Stage IV Wilms' tumor
690. Stage IV adrenocortical cancer
691. Stage IV adult Hodgkin's lymphoma
692. Stage IV adult non-Hodgkin's lymphoma
693. Stage IV adult primary liver cancer
694. Stage IV anal cancer
695. Stage IV bladder cancer
696. Stage IV cancer of the uterus
697. Stage IV cancer of the vulva
698. Stage IV cervical cancer
699. Stage IV childhood liver cancer
700. Stage IV childhood non-Hodgkin's lymphoma
701. Stage IV chronic lymphocytic leukemia
702. Stage IV colorectal cancer
703. Stage IV cutaneous T-cell lymphoma
704. Stage IV endometrial cancer
705. Stage IV esophageal cancer
706. Stage IV extrahepatic bile duct cancer
707. Stage IV gallbladder cancer
708. Stage IV gastric cancer
709. Stage IV hypopharynx cancer
710. Stage IV kidney cancer
711. Stage IV laryngeal cancer
712. Stage IV lip and oral cavity cancer
713. Stage IV malignant mesothelioma
714. Stage IV melanoma
715. Stage IV mycosis fungoides and the Sézary syndrome
716. Stage IV nasopharyngeal cancer
717. Stage IV non-small cell lung cancer
718. Stage IV oropharynx cancer
719. Stage IV ovarian cancer
720. Stage IV pancreatic cancer
721. Stage IV prostate cancer
722. Stage IV renal cell cancer
723. Stage IV skin cancer
724. Stage IV soft tissue sarcoma
725. Stage IV transitional cell cancer of the renal pelvis and ureter
726. Stage I AIDS-related lymphoma
727. Stage I Wilms' tumor
728. Stage I adrenocortical cancer
729. Stage I adult Hodgkin's lymphoma
730. Stage I adult non-Hodgkin's lymphoma
731. Stage I adult primary liver cancer
732. Stage I anal cancer
733. Stage I bladder cancer
734. Stage I breast cancer
735. Stage I cancer of the uterus
736. Stage I cancer of the vulva
737. Stage I cervical cancer
738. Stage I childhood liver cancer
739. Stage I childhood non-Hodgkin's lymphoma
740. Stage I chronic lymphocytic leukemia
741. Stage I colorectal cancer
742. Stage I cutaneous T-cell lymphoma
743. Stage I endometrial cancer
744. Stage I esophageal cancer
745. Stage I extrahepatic bile duct cancer
746. Stage I gastric cancer
747. Stage I hypopharyngeal cancer
748. Stage I kidney cancer
749. Stage I laryngeal cancer
750. Stage I lip and oral cavity cancer
751. Stage I malignant mesothelioma
752. Stage I melanoma
753. Stage I multiple myeloma
754. Stage I mycosis fungoides and the Sézary syndrome
755. Stage I nasopharyngeal cancer
756. Stage I non-small cell lung cancer
757. Stage I oropharynx cancer
758. Stage I ovarian cancer
759. Stage I pancreatic cancer
760. Stage I prostate cancer
761. Stage I renal cell cancer
762. Stage I skin cancer
763. Stage I testicular cancer
764. Stage I transitional cell cancer of the renal pelvis and ureter
765. Stage V Wilms' tumor
766. Standard therapy
767. Stereotactic external-beam radiation
768. Stereotaxic radiosurgery
769. Steroid cream
770. Steroid drug
771. Steroid therapy
772. Stromagen
773. Study agent
774. Subependymal
775. Subjective improvement
776. Subset analysis
777. Subtenon
778. Sun's Soup
779. Superfractionated radiation therapy
780. Supplemental nutrition
781. Supplementation
782. Supraglottic laryngectomy
783. Surface electrode
784. Sweet elm
785. Symptom management
786. Synthetic protegrin analog
787. Synthetic retinoid
788. Systemic chemotherapy
789. Systemic radiation
790. T-cell acute lymphocytic leukemia
791. T138067
792. T4N5 liposomal lotion
793. T900607
794. TAC-101
795. TG4010
796. TLK286
797. TP-38 immunotoxin
798. TSEB therapy
799. TTI-237
800. TZT-1027
801. Talaporfin sodium
802. Talotrexin
803. Technetium tc 99m dextran
804. Telcyta
805. Tetrahydrouridine
806. Third-line therapy
807. Thoracalgia
808. Thoracodynia
809. Thymitaq
810. Tin Sn 117m DTPA
811. Tin ethyl etiopurpurin
812. Tocladesine
813. Topical chemotherapy
814. Total androgen blockade
815. Total estrogen blockade
816. Total laryngectomy
817. Total nodal irradiation
818. Total skin electron beam radiation therapy
819. Traditional acupuncture
820. Transabdominal ultrasound
821. Transferrin-CRM107
822. Transvaginal sonography
823. Traumeel S
824. Treatment field
825. Trigger point acupuncture
826. Tumor-derived
827. Tumor burden
828. Tumor load
829. Tumor model
830. Tumor vasculature–targeted tumor necrosis factor alpha
831. Tumor volume
832. Tyrosinase peptide
833. UCN-01
834. Ultraviolet radiation therapy
835. Uncontrolled study
836. Unconventional cancer treatments
837. Unilateral salpingo-oophorectomy
838. Unresectable
839. Unresectable gallbladder cancer
840. Unresected
841. Unsealed internal radiation therapy
842. Ureteronephrectomy
843. Urologic oncologist
844. VEGF-AS
845. VEGF Trap
846. VNP20009
847. VNP40101M
848. VX 853
849. Vaccinia CEA vaccine
850. Valerianae radix
851. Vascular endothelial growth factor-antisense oligonucleotide
852. Velafermin
853. Video-assisted resection
854. Video-assisted surgery
855. Virulizin
856. Virus-neutralizing antibody
857. Well-differentiated lymphocytic lymphoma
858. Whole cell vaccine
859. Wild clover
860. Wobe-Mugos E
861. Xentuzumab
862. XK469R
863. XR9576
864. XRP9881
865. Xyotax
866. YM598
867. Yangona
868. ZD0473

• Missing encyclopedic articles (medicine)